GlycoMimetics, Inc Earning Date (GLYC)

USA |NASDAQ |USD

GLYC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 3, 2022 Jun 2022 - - $-0.28
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 3, 2022 Jun 2022 - - $142.00

Glycomimetics, Inc's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.

GLYC Earnings Date & History Chart

GLYC Earnings & Revenue Forecast

GLYC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $-1.35 $-1.49 $-1.26

GLYC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 1 $-1.33 $-1.30 $-1.30

GLYC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $0.00 $0.00 $0.00

GLYC Earnings Date & Revenue History

GLYC Earnings History

|
Show More
Show More

GLYC Revenue History

|
Show More
Show More

Glycomimetics, Inc Next Earnings Date & Report

GLYC Next Earnings Date & Report Preview: Jun 2022 (FQ)

GLYC's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

Glycomimetics, Inc Previous Earnings Dates & Reports

GLYC Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Glycomimetics, Inc's previous earnings date was May 2, 2022 for its fiscal quarter ended Mar 31, 2022.

GLYC Previous Earnings Date & Report Recap: Dec 2021 (FY)

Glycomimetics, Inc's previous annual earnings date was Mar 3, 2022 for its fiscal year ended Dec 31, 2021.

GLYC's earnings per share (EPS) was $-1.23, beating the consensus analysts forecast of $-1.26 by -2.38% , and lower than the previous year's EPS (Dec 2020) by 10.81%.

Revenues were $1.16K, worse than the forecast of $1.13M by -99.90%, and down by -99.99% from previous year's revenue.

Glycomimetics, Inc reported a free cash flow of $-57.50M for its fiscal year, compared to $-39.31M a year ago.

The company ended the fiscal year with $918.61K in total debt, a decrease of -67.41% compared to the previous year.